Company · NVO (New York Stock Exchange)
Novo Nordisk A S
Pharmaceutical Preparations
Key figures
- Revenue, 2025
- $46.32B
- Employees
- 69,505
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Institutional holders
- 1,349 at 30 Jun 2026 (1,278 the quarter before)
- SEC number
- 353278
- LEI
- 549300DAQ1CVT6CXN342
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026
About
Novo Nordisk A S is a Danish pharmaceutical company in pharmaceutical industry, headquartered in Bagsværd, founded in 1923.
Source: Wikidata
Latest filings
19 Oct 2026
6-K FORM 6-K
13 Oct 2026
6-K FORM 6-K
6 Oct 2026
6-K FORM 6-K
5 Oct 2026
6-K FORM 6-K
28 Sept 2026
6-K FORM 6-K
Source: SEC EDGAR
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.